Compare Mutual Funds
Risk
Very High
-
Rating
-
-
Min SIP Amount
₹1000
-
Expense Ratio
2.37
-
NAV
₹10.01
-
Fund Started
19 Nov 2024
-
Fund Size
₹88.38 Cr
-
Exit Load
Exit load of 0.50%, if redeemed within 90 days.
-
1 Year
11.84%
-
3 Year
-
-
5 Year
-
-
Equity
97.80%
-
Cash
0.02%
-
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 11.31% |
Divi's Laboratories Ltd. | 10.32% |
Dr. Reddy's Laboratories Ltd. | 6.36% |
Aster DM Healthcare Ltd. | 6.24% |
JB Chemicals & Pharmaceuticals Ltd. | 6.09% |
Max Healthcare Institute Ltd. | 5.33% |
Rubicon Research Ltd. | 5.00% |
Mankind Pharma Ltd. | 4.95% |
Ajanta Pharma Ltd. | 4.80% |
Abbott India Ltd. | 3.74% |
-
Name
-
-
Start Date
-
-
Description
The scheme seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
-
Launch Date
19 Nov 2024
-
